↓ Skip to main content

Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression

Overview of attention for article published in PLOS ONE, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs
1 blog
patent
5 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
395 Dimensions

Readers on

mendeley
210 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Published in
PLOS ONE, September 2009
DOI 10.1371/journal.pone.0006951
Pubmed ID
Authors

Cristin D. Davidson, Nafeeza F. Ali, Matthew C. Micsenyi, Gloria Stephney, Sophie Renault, Kostantin Dobrenis, Daniel S. Ory, Marie T. Vanier, Steven U. Walkley

Abstract

Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused most commonly by a defect in the NPC1 protein and characterized by widespread intracellular accumulation of unesterified cholesterol and glycosphingolipids (GSLs). While current treatment therapies are limited, a few drugs tested in Npc1(-/-) mice have shown partial benefit. During a combination treatment trial using two such compounds, N-butyldeoxynojirimycin (NB-DNJ) and allopregnanolone, we noted increased lifespan for Npc1(-/-) mice receiving only 2-hydroxypropyl-beta-cyclodextrin (CD), the vehicle for allopregnanolone. This finding suggested that administration of CD alone, but with greater frequency, might provide additional benefit.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Portugal 1 <1%
Denmark 1 <1%
Germany 1 <1%
Unknown 206 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 42 20%
Researcher 32 15%
Other 23 11%
Student > Bachelor 19 9%
Student > Master 18 9%
Other 31 15%
Unknown 45 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 53 25%
Biochemistry, Genetics and Molecular Biology 34 16%
Medicine and Dentistry 26 12%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Neuroscience 7 3%
Other 24 11%
Unknown 54 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2021.
All research outputs
#1,791,682
of 22,655,397 outputs
Outputs from PLOS ONE
#23,062
of 193,429 outputs
Outputs of similar age
#5,646
of 91,615 outputs
Outputs of similar age from PLOS ONE
#72
of 521 outputs
Altmetric has tracked 22,655,397 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 193,429 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 91,615 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 521 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.